

HY-14908A · 50 mg
MedChemExpress · Cat: HY-14908A
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/vidofludimus-hemicalcium.htmlDescription
Vidofludimus 4sc-101; SC12267 hemicalcium is an orally active inhibitor for dihydroorotate dehydrogenase DHODH and also is a novel modulator for farnesoid X receptor FXR . Vidofludimus hemicalcium, as an immunomodulatory agent, can be used for the research of autoimmune disorders such as inflammatory bowel disease IBD . Vidofludimus hemicalcium also can be used for the research of fatty liver by targeting FXR.







